These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34924268)

  • 101. Novel modified quantitative index for cone-beam CT assessment of medication-related osteonecrosis of the jaw - comparative analysis with original index.
    Badabaan G; Strickland M; Singer SR; Creanga AG; Subramanian G
    Saudi Dent J; 2023 May; 35(4):310-316. PubMed ID: 37251718
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Quantitative indices for cone-beam CT assessment of Medication-Related Osteonecrosis of the Jaw - a scoping review.
    Badabaan G; Creanga AG; Singer SR; Strickland M; Subramanian G
    Saudi Dent J; 2023 Feb; 35(2):133-140. PubMed ID: 36942207
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Texture analysis in cone-beam computed tomographic images of medication-related osteonecrosis of the jaw.
    Queiroz PM; Fardim KC; Costa ALF; Matheus RA; Lopes SLPC
    Imaging Sci Dent; 2023 Jun; 53(2):109-115. PubMed ID: 37405203
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Evaluation of quality of life in posttreatment upper aerodigestive tract cancer patients.
    Sujith A; Sharma N; Guruprasad R; Gupta M
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S234-S240. PubMed ID: 37148000
    [TBL] [Abstract][Full Text] [Related]  

  • 105. RE: MEDICATION-RELATED OSTEONECROSIS OF THE JAW (MRONJ).
    Bedogni A; Fusco V; Di Fede O; Bettini G; Panzarella V; Mauceri R; Saia G; Campisi G
    J Oral Maxillofac Surg; 2022 Jan; 80(1):2-3. PubMed ID: 34666036
    [No Abstract]   [Full Text] [Related]  

  • 106. [Not Available].
    Bornstein MM; Yeung AWK; Tanaka R; Su RY
    Swiss Dent J; 2020 May; 130(5):426-427. PubMed ID: 38095647
    [No Abstract]   [Full Text] [Related]  

  • 107. Is Tele-Dentistry an Effective Approach for Patient Follow-up in Maxillofacial Surgery.
    Torul D; Kahveci K; Kahveci C
    J Maxillofac Oral Surg; 2021 May; 22(3):1-7. PubMed ID: 34092957
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
    Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
    Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Risk Factors for Bisphosphonate-Related Osteonecrosis of the Jaws in Bone Metastatic Breast and Prostate Cancer under Zoledronate Treatment: A Retrospective Analysis from 10 Years of Evaluation.
    Aragão Matos Carlos AC; Moreira Caetano Coelho L; Nóbrega Malta CE; Aragão Magalhães I; Fontes Borges MM; Da Silva Júnior JE; Gonzaga Silva LF; De Barros Silva PG
    Asian Pac J Cancer Prev; 2023 Aug; 24(8):2681-2689. PubMed ID: 37642054
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Oral Health-Related Quality of Life and Mental Health Impairment in Patients Affected by Medication-Related Osteonecrosis of the Jaws: A Case-Control Pilot Study.
    Calabria E; Antonelli A; Barone S; Adamo D; Salviati M; Cerra MG; Bennardo F; Giudice A
    Dent J (Basel); 2023 Jun; 11(6):. PubMed ID: 37366670
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Comparing the Influence of Surgical and Conservative Therapy on Quality of Life in Patients with Early-Stage Medication-Related Osteonecrosis of the Jaw-A Prospective Longitudinal Study.
    Rückschloß T; Smielowski M; Moratin J; Schnug G; Appel M; Muench P; Bleymehl M; Zittel S; Engel M; Hoffmann J; Ristow O
    Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837478
    [No Abstract]   [Full Text] [Related]  

  • 112. Medication-related osteonecrosis of the jaws and quality of life: review and structured analysis.
    Murphy J; Mannion CJ
    Br J Oral Maxillofac Surg; 2020 Jul; 58(6):619-624. PubMed ID: 32247520
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Factors affecting the quality of life of patients with medication-related osteonecrosis of the jaw during treatment: A quality-of-life survey and causal analysis.
    Munakata K; Miyashita H; Yamada Y; Soma T; Iwasaki R; Nakagawa T; Asoda S
    J Craniomaxillofac Surg; 2024 Jun; 52(6):715-721. PubMed ID: 38582669
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Treatment outcomes and prognostic factors of medication-related osteonecrosis of the jaw: a case- and literature-based review.
    Yamada SI; Kurita H; Kondo E; Suzuki S; Nishimaki F; Yoshimura N; Morioka M; Ishii S; Kamata T
    Clin Oral Investig; 2019 Aug; 23(8):3203-3211. PubMed ID: 30406491
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Development and evaluation of the clinimetric properties of the Medication-Related Osteonecrosis of the Jaw Quality of Life Questionnaire (MRONJ-QoL).
    El-Rabbany M; Blanas N; Sutherland S; Shah PS; Lam DK; Azarpazhooh A
    Int J Oral Maxillofac Surg; 2022 Jun; 51(6):768-775. PubMed ID: 34924268
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Surgical Therapy in Patients With Medication-Related Osteonecrosis of the Jaw Is Associated With Disease Resolution and Improved Quality of Life: A Prospective Cohort Study.
    El-Rabbany M; Blanas N; Sutherland S; Lam DK; Shah PS; Azarpazhooh A
    J Oral Maxillofac Surg; 2022 Jun; 80(6):1084-1093. PubMed ID: 35183496
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Quality of life in cancer patients with or without medication-related osteonecrosis of the jaw.
    de Cassia Tornier S; Macedo FJ; Sassi LM; Schussel JL
    Support Care Cancer; 2021 Nov; 29(11):6713-6719. PubMed ID: 33973080
    [TBL] [Abstract][Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.